Equities Research Analysts’ upgrades for Tuesday, November 14th:

Cooper Companies, Inc. (The) (NYSE:COO) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $257.00 target price on the stock. According to Zacks, “The Cooper Companies has had an impressive run on the bourse over the last six months. The company has seen strong growth at its CooperVision business segment of late. Notably, the segment banks on the platforms of MyDay, Clariti and Biofinity silicone hydrogel lenses. The CooperSurgical segment also delivered strong sales in the quarter. A strong guidance for fiscal 2017 instills our confidence on the stock. Cooper Companies has completed the acquisition of Procornea in the recent past. This added a leading ortho-k technology to Cooper Company’s lens portfolio and marked its foray in the emerging myopia controlled markets. However, the dampening outlook for the CooperSurgical segment indicates looming concerns. Furthermore, intensifying competition in the contact-lens space will continue to increase pricing pressure. Added to this, escalating debt levels and foreign exchange vulnerability are likely to mar the company;s bottom line.”

Dollar General Corporation (NYSE:DG) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $94.00 target price on the stock. According to Zacks, “Dollar General’s commitment toward better price management, merchandise initiatives and cost containment has helped the stock to outperform the industry in the past six months. Strategic endeavors have helped it to deliver better-than-expected numbers for the third straight quarter, as it posted second-quarter fiscal 2017 results. Upbeat performance and buyout of Acquired Stores prompted management to raise earnings outlook. The company anticipates earnings in the band of $4.35-$4.50 per share, up from the earlier estimate of $4.25-$4.50. Despite robust performance, investors’ remained concerned over cut in SNAP benefit. Trump’s suggestion of reducing food stamps program by $193 billion, which is nearly 25% of the budget for the program, will have a detrimental effect. Cut in SNAP benefit will hamper performance as people with low income will have less money to spend and could restrict spending to low margin products.”

Equifax (NYSE:EFX) was upgraded by analysts at Zacks Investment Research from a strong sell rating to a hold rating. According to Zacks, “Equifax’s third-quarter 2017 results were disappointing. The results bear the brunt of data breach as customers were cautious about the company’s cybersecurity practices and deferred purchases. Management hinted that this factor may have a greater negative impact on the forthcoming quarter sales. Additionally, with lawmakers and investigating agencies probing the mishap, troubles for Equifax are unlikely to end any time soon. Notably, shares have underperformed the industry on YTD basis. Nonetheless, we believe that management’s efforts, such as strategic initiatives for product innovation and expansion of data assets through acquisitions should act as tailwinds. Also, the company’s strong correlation with the consumer and financial markets, and exposure in the U.S. and Europe are likely to propel growth.”

Sunoco Logistics Partners (NYSE:ETP) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $19.00 price target on the stock. According to Zacks, “Energy Transfer Partners is well poised to grow on the back of its geographically dispersed asset mix. The partnership delivered better than expected Q3 earnings on higher volumes and revenues. ETP is reaping rewards from its major projects including Rover Pipeline, Bakken Pipeline and Permian Express 3 which are expected to strengthen the growth momentum of the partnership in the future. Further, Sunoco’s merger with Energy Transfer has boosted the growth and value of the partnership and is likely to lead to $200 million of cost savings by 2019. Acquisition of PennTex is also expected to provide additional long term opportunities to ETP. We also like ETP's growing cash distribution which witnessed a year-over-year increase of over 40% in the recent quarter. All these factors form the basis of our bullish stance on the prospects of the stock.”

Intuitive Surgical (NASDAQ:ISRG) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $436.00 price target on the stock. According to Zacks, “Over the last three months, Intuitive Surgical has been consistently trading above the broader industry. Its third quarter earnings and revenues both topped the Zacks Consensus Estimate. The company’s procedure performance in Asia showed continued strength with solid growth in China, Japan and Korea. Intuitive Surgical gained significantly on the CE Mark approval for da Vinci X in Europe. The stock received further boost on the recent FDA approval of the same. Also, a solid outlook for the coming quarters also raises our confidence in the stock. Further, incremental spending on product development and higher investments in international markets are prudent moves that are likely to drive long-term growth. The company is also expected to enhance its organizational capabilities and gain prominence in the markets of Europe and Asia.”

QuickLogic Corporation (NASDAQ:QUIK) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $2.00 target price on the stock. According to Zacks, “QuickLogic Corporation is a semiconductor provider of ultra-low power, comprehensive, flexible sensor processing solutions enabling significantly longer battery life for the Smartphone, Wearable, and IoT markets. They are the only company integrating multi-core processing, programmable logic, sensor fusion and context aware algorithms, and embedded software. QuickLogic accelerates the pace of innovation for always-on motion, light, environmental, location, and voice-enabled user experiences. “

Renewable Energy Group (NASDAQ:REGI) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Renewable Energy Group, Inc. produces and sells biofuels and renewable chemicals in the U.S. It operates through Biomass-Based Diesel, Services, Renewable Chemicals, and Corporate and Other segments. It produces biomass-based diesel from a range of feedstocks, including inedible corn oil, used cooking oil, soybean oil, canola oil, and inedible animal fat. This segment is also involved in the purchase and resale of biomass-based diesel, petroleum-based diesel, renewable identification numbers, and raw material feedstocks acquired from third parties; and sale of glycerin, free fatty acids, naphtha, and other co-products of the biomass-based diesel production process. The Services segment provides facility management and operational services to biomass-based diesel production facilities, as well as to other clean-tech companies. This segment also offers construction management services for biomass-based diesel production facilities. REG is committed to being a long-term leader in bio-based fuel and chemicals. “

RingCentral (NYSE:RNG) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. The firm currently has $52.00 target price on the stock. According to Zacks, “RingCentral, Inc. provides solutions for business communications primarily in the United States. The Company’s products include RingCentral Office, RingCentral Mobile and RingCentral Fax. It provides solutions such as auto-receptionist, flexible extension structure, multiple voicemail boxes, smart call routing, business answering rules, extension dialing, call transfers and elegant integration with Smartphones. RingCentral, Inc. is headquartered in San Mateo, California. “

Ignyta (NASDAQ:RXDX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $18.00 price target on the stock. According to Zacks, “Ignyta, Inc. is a biotechnology company. It develops precision medicine with integrated Rx/Dx solutions for cancer patients. The company focuses on the development of RXDX-101, its proprietary oral tyrosine kinase inhibitor that targets solid tumor indications, and advancing its novel Spark discovery programs that leverage its proprietary cancer genomic and epigenomic knowledge bases. Ignyta, Inc. is based in San Diego, California. “

SCYNEXIS (NASDAQ:SCYX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $2.00 price target on the stock. According to Zacks, “SCYNEXIS, Inc. is a pharmaceutical company. It is engaged in the discovery, development, and commercialization of anti-infectives to address unmet therapeutic needs. The Company is developing its lead product candidate, SCY-078, as an oral and intravenous (IV) drug for the treatment of serious and life-threatening invasive fungal infections in humans. It also provides contract research and development services. SCYNEXIS, Inc. is headquartered in Durham, North Carolina. “

Superior Drilling Products (NASDAQ:SDPI) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $1.25 price target on the stock. According to Zacks, “Superior Drilling Products, Inc. operates as a manufacturer and remanufacturer of PDC (polycrystalline diamond compact) drill bits and drill string tools for the oil, natural gas and mining services industries. It also provides manufacturing, leasing, and refurbishing of drill string tools to oil field services clients. Superior Drilling Products, Inc. is based in United States. “

SolarEdge Technologies (NASDAQ:SEDG) was upgraded by analysts at Zacks Investment Research from a hold rating to a strong-buy rating. Zacks Investment Research currently has $44.00 price target on the stock. According to Zacks, “SolarEdge Technologies, Inc. provides inverter solution. The company’s SolarEdge system offers power optimizers, inverters and a cloud-based monitoring platform. It serves residential solar installations to commercial and small utility-scale solar installations. SolarEdge Technologies, Inc. is headquartered in Hod Hasharon, Israel. “

Peak Resorts (NASDAQ:SKIS) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Peak Resorts, Inc. is an owner and operator of ski resorts in the U.S. The resorts under the company’s umbrella offer a breadth of activities, services and amenities, including skiing, snowboarding, terrain parks, tubing, dining, lodging, equipment rentals and sales, ski and snowboard instruction and mountain biking and other summer activities. Its ski properties are located throughout the Midwest, Northeast and Southeast United States. Peak Resorts, Inc. is headquartered in Wildwood, Missouri. “

Tanger Factory Outlet Centers (NYSE:SKT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Tanger Factory Outlet Centers, Inc. is a fully-integrated, self-administered and self-managed real estate investment trust which focuses exclusively on developing, acquiring, owning and operating factory outlet centers. Since entering the factory outlet center business, they have become one of the largest owners and operators of factory outlet centers in the United States. “

Summit Therapeutics PLC (NASDAQ:SMMT) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Summit Therapeutics PLC is engaged in the discovery and development of drug to treat the fatal muscle wasting disease Duchenne Muscular Dystrophy and infections caused by the bacteria C. difficile. Summit Therapeutics PLC is headquartered in Abingdon, the United Kingdom. “

Suburban Propane Partners, L.P. (NYSE:SPH) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Suburban Propane Partners, L.P., a publicly traded Delaware limited partnership is engaged, through subsidiaries, in the retail and wholesale marketing of propane and related appliances and services. The Partnership believes it is the third largest retail marketer of propane in the United States, Suburban Propane Partners serves active residential, commercial, industrial and agricultural customers from customer service centers in over 40 states. The Partnership’s operations are concentrated in the east and west coast regions of the United States. “

ProNAi Therapeutics (NASDAQ:SRRA) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Sierra Oncology, Inc. is a clinical-stage drug development company. It develops and markets drugs for the treatment of cancer. The product pipeline consists of SRA737 and SRA141. SRA737 is an orally bioavailable small molecule inhibitor of Checkpoint kinase 1, a key cell cycle checkpoint and central regulator of the DNA Damage Response network. SRA141 is an orally available small molecule inhibitor of cell division cycle 7kinase. Sierra Oncology, Inc., formerly known as ProNAi Therapeutics, Inc., is headquatered in Vancouver, Canada. “

Receive News & Stock Ratings for Cooper Companies Inc (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cooper Companies Inc (The) and related stocks with our FREE daily email newsletter.